INTRODUCTION
Studying the biological consequences of the disruption of proteinprotein interactions is a direct means to validate their relevance in cellular processes as well as in disease. Moreover, the identification of peptides or small molecules that specifically interfere with protein interactions might lead to the development of new drugs (1) . The reverse two-hybrid system has been developed to readily identify events that can disrupt protein-protein interactions in vivo. This system is based on the interaction-dependent activation of a reporter gene, whose product inhibits growth of the engineered yeast cell under selective conditions. Thus, disruption of the interaction between the hybrid proteins reduces the expression of the negative marker gene and provides a selective advantage for cell growth. Several yeast toxic markers have been used for negative selection, most notably the URA3 and CYH2 genes (2, 3) .
The URA3 gene, which is required for uracil biosynthesis, has been most widely used as a marker because it allows both positive and negative selection of its expression (4) . While positive selection is performed on media lacking uracil, selection against URA3 expression is performed on plates containing 5-fluoroorotic acid (5-FOA), which is metabolized into a toxic compound by orotidine 5′ decarboxylase, the URA3 gene product (4, 5) . The use of the URA3 gene as a counter-selectable marker has been successful in the case of screens for mutations in one of the interacting partners that disrupt the protein-protein interaction (5) . However, its application in larger scale screens of high-complexity peptide or small molecule libraries is unlikely due to (i) the general high background of unspecific growth in the presence of 5-FOA (3); (ii) the laborious procedure of replica plating that is necessary for this selection assay; and (iii) the high cost of 5-FOA as a selective reagent (6) . The yeast CYH2 gene, which encodes the ribosomal protein Rpl28, provides an alternative counter-selection assay for the reverse two-hybrid system. Indeed, activation of the expression of this reporter gene by interacting protein partners confers cycloheximide sensitivity to yeast cells that are otherwise resistant due to a mutation in the endogenous CYH2 allele (7) . This system has been successfully applied for screening a small molecule library to identify compounds that could interfere with protein-protein interactions involved in ion channel function (8) . Its use in large-scale screens of peptideexpressing DNA libraries has not yet been determined.
We have developed a novel counter-selection assay that is based on the toxicity of intracellular galactose-1-phosphate. This derivative of galactose accumulates and reaches toxic concentrations upon the expression of a galactokinase-encoding GAL1 reporter gene in the absence of transferase activity encoded by the GAL7 gene, which catalyzes the conversion of galactose-1-phosphate into glucose-1-phosphate. 
MATERIALS AND METHODS

Plasmids and Yeast Strains
The integrating reporter plasmid 6xLexBS-Int-Leu was constructed by inserting the LEU2 nutritional marker gene into pDE94-6xLexBS-GAL1. pDE94-6xLexBS-GAL1, which carries the lacZ and GAL1 reporter genes expressed from a bidirectional promoter with six LexA-binding sites, was derived from pDE94, pDE200 (9) , and pBS-GAL1. To construct pBS-GAL1, the GAL1 gene was amplified by PCR (Pfu polymerase; Stratagene, La Jolla, CA, USA) using yeast genomic DNA as a template with primers carrying a SalI and KpnI site, respectively. The DNA fragment was digested with the appropriate enzymes and cloned into SalI-and KpnI-digested pBluescript ® SK (Stratagene). The GAL1-10 promoter region was amplified by PCR using pDE94 as a template.
The GAL1 reporter plasmid 6xLex-BS-Int-Leu was linearized at the AflII site within the LEU2 marker gene and integrated into the genomic leu2Δ1 locus of the strain JPY9 (MATα ura3-52 his3Δ200 leu2Δ1 trp1Δ63 lys2Δ385 gal4Δ11) (10) , resulting in the strain YST5. The URA3-marked reporter plasmid pDE94-6xLexBS-GAL1 was instead linearized at the BstBI site in the URA3 gene and integrated into the genomic ura3-52 locus of JPY9, resulting in YTG2.
The (10) . The expression plasmid LexA-Gcn4 has also been described elsewhere (12) . The Ω-graft-GAL4AD expression construct was derived from the AD-Ω-graft construct (12) and subcloned into NcoI/ SalI-digested pSO111 (10) . The Gcn4 peptide open reading frame was generated by PCR from pAdM010 described by Wörn et al. (13) as a template and a pair of primers containing NotI and SalI sites. This PCR product encoding the last 32 amino acids from the proline mutant Gcn4p was then cloned into pESBA-Act cut with SalI and NcoI. All primer sequences are available upon request from the authors.
β-Galactosidase Assays
The β-galactosidase assay was performed using permeabilized cells (13) . Activity was normalized to the number of cells assayed. All measurements were performed in triplicate, and the average values are given.
Yeast Growth and Manipulations
Yeast genetic techniques and media were as previously described (14) . For the selection of plasmids, drop-out media containing all except the specified amino acids were used. Yeast transformation was performed by the lithium acetate procedure (15) . For the growth assays on plates: the GAL1 yeast strain (STY2) was transformed with the indicated plasmids, and the cells were plated on selective plates (-his/-leu/ -trp/-ura) containing 2% glucose or 3% galactose, 2% raffinose, and 2%
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glycerol instead of glucose. For the growth assays in liquid yeast cultures: transformed yeast cells were grown overnight at 30°C in glucose drop-out medium (-his/-leu/-trp/-ura). The saturated cultures were diluted to an A 600 of 0.03 in 3 mL galactose drop-out medium (-his/-leu/-trp/-ura, containing 3% galactose, 2% raffinose, and 2% glycerol) or 3 mL glucose drop-out medium. The cultures were incubated at 30°C, and an A 600 was measured after 21 h.
Determination of the Frequency of Revertants
Cells transformed with LexA-Gcn4 and Ω-graft-GAL4AD or LexA-MAX and LexA(1-87)-MYC-VP16 were plated on glucose and galactose/raffinose/ glycerol plates. The transformation efficiency was determined by counting the number of colonies growing on glucose plates. Five days after transformation, the number of revertants appearing on galactose/raffinose/glycerol plates was counted.
RESULTS
Strategy of the GAL1 Reverse TwoHybrid System
The aim of our work was to develop a reverse two-hybrid system based on the expression of the yeast GAL1 gene as a counter-selectable marker for the identification of disrupted protein-protein interactions. Galactokinase, the enzyme encoded by the GAL1 gene, converts intracellular galactose into galactose-1-phosphate. In wild-type cells, galactose-1-phosphate is further metabolized by the product of the GAL7 gene, the uridyl transferase, to uridine diphosphate (UDP)-galactose and glucose-1-phosphate. In contrast, in cells lacking GAL7 function, but still carrying an active GAL1 gene, galactose-1-phosphate accumulates to levels that are toxic to the cell metabolism ( Figure  1A ). Therefore, these cells are not only unable to metabolize galactose and to grow in the presence of this sugar as the only carbon source but are also unable to grow on other carbon sources added to galactose because of toxic galactose-1-phosphate (16) . In these cells, the reduction of the GAL1 reporter gene expression by molecules that disrupt protein interaction ( Figure 1B ) would diminish the intracellular concentration of galactose-1-phosphate, thus allowing growth on media containing galactose mixed with an additional and utilizable carbon source. For the GAL1 reverse two-hybrid system described here, we constructed the yeast strains YTG2 and YST5, which do not express the GAL7-encoded uridyl transferase and carry the divergently oriented reporter genes lacZ and GAL1 under the control of six LexA-binding sites ( Figure 1B ; see the Materials and Methods section). While the GAL1 reporter gene enables the counter selection of interaction-dependent activation, the lacZ gene allows for the quantification of reporter gene activity.
Inhibition of Cell Growth Is Dependent on a Protein-Protein Interaction that Can Activate GAL1 Gene Expression
We first tested our GAL1 reporter system by investigating gene activation elicited by a well-characterized interaction between an intracellular stable single-chain antibody fragment (scFv) and its antigen. This interaction has been previously shown to activate transcription in a two-hybrid setting (13) . For this purpose, the scFv called Ω-graft was expressed as a fusion protein with the gal4p activation domain, and its antigen, the leucine-zipper dimerization domain of the transcription factor Gcn4, was fused to the DNA-binding protein LexA (12) .
The hybrid proteins were expressed in the yeast strain YTG2, and activation of the lacZ reporter gene was measured by β-galactosidase assay. In agreement with previous results, the interaction of the Ω-graft scFv with the Gcn4 leucine zipper as part of the two-hybrid proteins caused the activation of the lacZ reporter gene, whereas the expression of either one of the binding partners did not stimulate transcription of the lacZ gene ( Figure 2A, lines 1, 3 , and 4). We then tested whether the Ω-graft-Gcn4 leucine zipper interaction that activated the lacZ gene would also be able to activate transcription of the GAL1 reporter gene such as to inhibit growth on galactose/raffinose/glycerol plates. Figure  2B shows that yeast cells that expressed both hybrid proteins did not grow on plates containing galactose, raffinose, Figure 1 . Representation of the galactose utilization pathway and the counter-selectable GAL1 reporter system. (A) The GAL2 gene product promotes internalization of extracellular galactose (gal), which is then converted to galactose-1-phosphate (gal-1-P) by the GAL1 gene product (galactokinase). The GAL7 gene product (uridyl transferase) catalyzes the production of glucose-1-phosphate (glu-1-P) and UDP-galactose (in gray). Mutants lacking the GAL7 function accumulate gal-1-P, which is toxic to the cell. Figure 2B, left column) . We observed that a few cells expressing the interacting partners escaped selection on galactose/raffinose/glycerol plates ( Figure 2B , right column, first row). We do not know how these cells ("revertants") escape selection. Somehow they seem to suppress the expression of the reporter genes because the lacZ gene was inactive in all the revertants that were tested (data not shown). Cells that escape selection would score as false positives in a reverse two-hybrid screen. We determined the frequency of these revertants by collecting data from several experiments and found that, in the case of counter selection for the Ω-graft-Gcn4 leucine zipper interaction, it is approximately 8-10 in 10 6 transformed cells (see the Materials and Methods section). Such a number of potential false positives should also be manageable in a large-scale screening experiment.
Disruption of the Interaction Between Hybrid Proteins Restores Cell Growth Under Selective Conditions
We next tested whether a short peptide that has been previously shown to interfere with this antibody-antigen interaction in vitro (13) could also function as a competitive inhibitor in the GAL1 reverse two-hybrid system in vivo. For this experiment, we transformed our reporter yeast strain YTG2 with a vector expressing the peptide, which comprises the antibody epitope on Gcn4 (see Materials and Methods and Reference 17), together with the two interacting hybrid proteins. Overexpression of the Gcn4 peptide caused the reduction of lacZ gene expression level elicited by the Ω-graft and the Gcn4 hybrid proteins by about 55% (Figure 2A, line 2) . In the GAL1-dependent growth assay on plate, this level of inhibition of the Ω-graft-Gcn4 leucine zipper interaction was clearly sufficient to efficiently rescue growth of yeast cells on galactose/raffinose/glycerol plates ( Figure 2B , right column, second row).
For some screening assays, such as a screen of small molecule libraries, it would be more convenient to select for growth in liquid culture instead of growth on plates (18) . Therefore, we checked whether the GAL1-dependent growth selection assays could also be performed in liquid culture. Figure 2C shows that, in selective liquid medium (galactose/raffinose/glycerol), interaction between the Ω-graft and the Gcn4 hybrid proteins significantly inhibited growth, whereas expression of the competitive inhibitor of this interaction completely rescued it (compare line 2 with 3 for galactose/raffinose/glycerol). Thus, these results are very similar to those obtained by performing growth selection on plates ( Figure 2B , first and second rows). Taken together with the results of the lacZ gene expression experiments, the results of these growth selection assays indicate that a reduction of about 55% of reporter gene expression by the protein interaction inhibitor completely rescued yeast cell growth and could therefore be scored positively by the GAL1 reverse twohybrid system described here, both on plates and in liquid cultures.
The MYC-MAX Interaction Causes Reporter Gene Expression and Inhibition of Cell Growth
We next applied our GAL1 reverse two-hybrid system to the investigation of interactions between the human oncoprotein MYC and its partner MAX, which form heterodimers via their basic helix-loop-helix leucine zipper (bHLHZip) domains. Heterodimerization between MYC and MAX has been shown to be essential for the transformation and apoptotic properties of MYC (19) (20) (21) (22) . Thus, for further analysis of the biological role of these proteins as well as for potential therapeutic purposes, it would be very important to identify molecules that can efficiently block their interaction.
MYC is only a modest transcriptional activator in mammalian cells (23) and particularly so in yeast cells (data not PROTEOMIC TECHNOLOGIES shown). In order to obtain robust and reproducible reporter gene activation in yeast that is dependent on the MYC and MAX bHLHZip interaction, we constructed the following hybrid constructs. The bHLHZip domain of MAX (amino acid residues 28-99) was fused to the C terminus of the first 87 amino acids of LexA, generating the hybrid protein named LexA(1-87)-MAX. The MYC bHLHZip domain (amino acid residues 368-439) was inserted between the C terminus of LexA and the N terminus of the known VP16 activation domain, which provides a strong transcriptional activation function. This fusion protein was called LexA(1-87)-MYC-VP16. The N-terminal 87 amino acids of LexA contain the DNA-recognition sequence but lack the dimerization function of LexA, which is carried by its C-terminal region (amino acid residues 88-202) and is essential for DNA binding (24) . Thus, in these fusion proteins, the heterodimerizing bHLHZip domains of MYC and MAX replaced the dimerization domain of LexA.
The various LexA fusion proteins were expressed, either individually or in combination, in the yeast strain YST5, and activation of the lacZ reporter gene was measured by β-galactosidase assay. As a positive control for lacZ activation in this strain, we used the fusion protein LexA-GAL11 (10), a strong transcriptional activator ( Figure  3A was significant and reproducible, but not as strong as that elicited by LexA-GAL11. We also tested a MYC-VP16 fusion protein lacking the DNA-binding LexA(1-87) expressed together with the MAX moiety fused to full-length LexA (DNA binding plus dimerization domains) in a classical two-hybrid setting. However, these hybrid constructs stimulated lacZ gene expression only very weakly in our strain and could therefore not be applied to counter selection on galactose-containing plates (data not shown). Because individual expression of the fusion proteins did not stimulate reporter gene expression over background ( Figure 3A , lines 3 and 4), we conclude that, in our experiments, lacZ activation was dependent on the interaction between the bHLHZip domains of MYC and MAX fused to the DNA-binding LexA(1-87).
We then tested whether the MYC-MAX bHLHZip interaction that could activate the lacZ gene would be able to activate transcription of the GAL1 reporter gene to a level that is sufficient to inhibit growth on selective galactose/raffinose/glycerol plates. Combined and individual expression of twohybrid proteins in YST5, as well as the negative and positive controls (empty vector and LexA-GAL11, respectively) allowed similar growth rates on nonselective glucose plates ( Figure 3B , left column). The strong transcriptional activator LexA-GAL11 inhibited growth on selective plates containing galactose/raffinose/glycerol ( Figure 3B , right column, sixth row). Coexpression of LexA(1-87)-MAX with LexA(1-87)-MYC-VP16 also caused growth inhibition on selective plates ( Figure 3B , right column, first row). As in the case of the Ω-graft-Gcn4 leucine zipper interaction, some colonies escaped selection on these plates. In addition, for the MYC-MAX interaction, the number of these revertants corresponded to 8-10 in 10 6 transformed cells, suggesting that generating revertants is a process that is independent of the type of interacting hybrid proteins tested.
For further validation of the GAL1 reverse two-hybrid system, we compared the performance of our system with the CYH2-based reverse two-hybrid system. For this purpose, LexA(1-87)-MAX and LexA(1-87)-MYC-VP16
were coexpressed in a cycloheximideresistant yeast strain that carried the CYH2 reporter gene under the control of six LexA-binding sites (AA, TG, and AB; A. Auf der Maur, T. Gunde, and A. Barberis, unpublished results) similar to the GAL1 reporter construct described here. Coexpression of the MYC and MAX hybrid proteins in the presence of cycloheximide resulted in partial inhibition of cell growth, thus generating smaller colonies on selective plates. However, the level of CYH2 reporter gene activation elicited by MYC and MAX hybrid proteins was insufficient to confer complete sensitivity towards cycloheximide, even in the presence of a high cycloheximide concentration such as 20 µg/mL (data not shown). This suggests that the threshold level of transcriptional activation of the CYH2 gene required to confer complete sensitivity to cycloheximide is higher than the threshold level of GAL1 gene expression necessary to inhibit growth in the presence of galactose. Thus, in this case of the MYC and MAX interaction, the GAL1 reverse two-hybrid system was more sensitive than the CYH2-based reverse two-hybrid system.
Blocking the MYC-MAX Interaction Restores Cell Growth Both on Plate and in Liquid-Selective Media
We tested whether overexpression of the isolated bHLHZip domain of MYC (amino acid residues 368-439) could function as a competitive inhibitor of the MYC-MAX interaction in yeast, thereby reducing the expression of the lacZ and GAL1 reporter genes described above. Figure 3A Figure 3C , compare lines 1 to 5 for galactose/raffinose/glycerol medium). Growth in nonselective glucose medium was consistently more efficient than growth in the presence of galactose/raffinose/glycerol because glucose is generally a much preferred carbon source by Saccharomyces cerevisiae.
DISCUSSION
We have taken advantage of the toxicity of intracellular galactose-1-phosphate for developing a novel counterselection strategy using the yeast GAL1 gene as a negative selection marker. We have shown that two independent protein interactions inhibited yeast cell growth under selective conditions by the activation of the GAL1 reporter gene. This growth inhibition could be reversed by intracellular expression of specific competitive inhibitors of the tested protein-protein interactions. The interaction-dependent growth inhibition and its reversal through competition was clearly observed both on selective agar plates and in selective liquid cultures. The results of growth selection assays in liquid medium ( Figures 2C and 3C) show that our system can also be used for small molecule screens, which are more readily performed in liquid cultures. We have indeed recently applied our GAL1 reverse two-hybrid system in a 96-well plate automated screening of a small molecule library for identifying inhibitors of MYC-MAX dimerization. With this screening assay, we have identified compounds that specifically interfered with this protein interaction (S. Tanner and A. Barberis, unpublished results). While several classes of the selected chemical structures were novel with respect to this function, one of them displayed high similarity with the compound named 10074-A4 . Black bars indicate relative growth in selective liquid medium containing galactose, raffinose, and glycerol. In control assays, yeast cells were grown in nonselective glucose media in parallel (gray bars). As generally observed, growth in glucose medium was more robust than growth in galactose/raffinose/glycerol medium. Growth of LexA-Gal11 in glucose medium was arbitrarily set at 100%.
that was also recently identified in a yeast assay based on lacZ expression and shown to inhibit the MYC-MAX interaction in vitro (25) . These results provide support for the application of our cell growth selection assay in highthroughput screens of large compound libraries aimed at the identification of molecules that can function in an intracellular environment to interfere with protein-protein interactions.
The use of GAL1 as counter-selectable marker gene for reverse two-hybrid assays has technical advantages over the classical negative selection markers URA3 and CYH2. This counter-selection system does not require laborious replica-plating steps or the use of expensive and/or delicate drugs such as 5-FOA or cycloheximide, which are necessary to counter-select expression of URA3 and CYH2, respectively. Moreover, a suitable yeast strain can be easily obtained by the deletion of the GAL7 or the GAL4 gene and the subsequent integration of the reporter gene into the yeast genome using standard yeast genetics methods. While this is also usually easily achieved in the case of the URA3 system, experience with the CYH2 selection system shows that it is not a straightforward task to obtain a cycloheximide-resistant strain, which is required for CYH2 selection (Reference 7; A. Auf der Maur, T. Gunde, and A. Barberis, unpublished results). Regarding this selectable marker, at least in our assays for the MYC-MAX interaction, the GAL1 reverse two-hybrid system appeared to be more sensitive than the CYH2-based reverse two-hybrid system.
Selectivity is an important parameter that has to be assessed for all twohybrid assays. The higher the number of false positives in an assay, the more difficult and time-consuming the identification of true positives among false positives will be. While we learned that negative selection generally yields a higher number of false positives compared to positive selection in the classical two-hybrid system (26), 1-3 false positives in 10 4 tested cells as we have obtained by selecting against URA3 with 5-FOA (27) are too many to be practically and rapidly identified. Selection against GAL1 led to about 1 false positive in 10 5 tested cells-roughly 10 to 30 times fewer false-positive clones compared to 5-FOA selection.
Another important parameter for the choice of negative selection markers in reverse two-hybrid assays is sensitivity. While some mutations in one of the interaction domains can lead to complete disruption of the interaction and, consequently, to the loss of reporter gene expression, competitive inhibition by RESEARCH REPORT peptides or small molecules most frequently leads to only partial disruption of the interaction. Thus, in such cases, the expression of the negative selection marker gene persists at a reduced level even in the presence of the inhibitor. We could show that, although inhibition of protein-protein interactions and reduction of reporter gene expression by our model inhibitors did not exceed 50% (as estimated by comparison of the β-galactosidase values), growth was restored under selective conditions. Nevertheless, growth selection on plates seemed to yield a reduced colony number compared to the control plates, but the size of the individual colonies was not affected. The reduced colony number might be a consequence of the stress of transformation combined with the potentially toxic high expression level of the inhibitors. However, in liquid cultures, the growth rate was comparable to that of the control samples. Thus, we conclude that it is not necessary to have inhibition close to 100% in order to restore growth in our assay. This should allow us to select relatively weak inhibitors in a screening assay, thus broadening the variety of molecules as a starting point for further development.
